Point: Postprandial glucose levels are a clinically important treatment target

Diabetes Care

Volumn 33, Issue 8, 2010, Pages 1905-1910

  Ceriello, Antonio ^a   Davidson, Mayer B ^b  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; NATEGLINIDE; VALSARTAN;

CARDIOVASCULAR DISEASE; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; REVIEW; RISK FACTOR;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; HUMANS; POSTPRANDIAL PERIOD;

EID: 77958177730     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-0634     Document Type: Review

References (0)